(4-Chlorophenyl)acetic acid → 2-(4-chlorophenyl)-N-(7-oxo-4-phenylthieno[2,3-d]pyridazin-6(7H)-yl)acetamide
반응식
[NH2:1][N:2]1[C:7](=[O:8])[C:6]2[S:9][CH:10]=[CH:11][C:5]=2[C:4]([C:12]2[CH:17]=[CH:16][CH:15]=[CH:14][CH:13]=2)=[N:3]1.[Cl:18][C:19]1[CH:24]=[CH:23][C:22]([CH2:25][C:26](O)=[O:27])=[CH:21][CH:20]=1>>[Cl:18][C:19]1[CH:24]=[CH:23][C:22]([CH2:25][C:26]([NH:1][N:2]2[C:7](=[O:8])[C:6]3[S:9][CH:10]=[CH:11][C:5]=3[C:4]([C:12]3[CH:17]=[CH:16][CH:15]=[CH:14][CH:13]=3)=[N:3]2)=[O:27])=[CH:21][CH:20]=1참가 물질
3
실험 절차
The product from Example 29B and 2-(4-chlorophenyl)acetic acid were processed using a method similar to that described in Example 17C to afford the title compound. 1H NMR (500 MHz, DMSO-d6) δ ppm 3.72 (s, 2H) 7.41 (s, 4H) 7.56 (dd, J=4.42, 2.59 Hz, 4H) 7.63-7.80 (m, 2H) 8.36 (d, J=5.19 Hz, 1H) 11.81 (s, 1H); MS (ESI) m/z 396 (M+H)+.
출처 및 근거
- ORD 기록
- ord-569cedc8c16a4652b39a41756d933995
- 출처 데이터셋
- uspto-grants-2014_01